Careology is an app that helps people going through cancer treatment log symptoms, medicines and appointments, and a dashboard that lets their hospital team see problems early.
Careology is a London based digital cancer care platform founded by Paul Landau. Patients use the app to record symptoms, temperature, medication and wellbeing, and clinical teams monitor a dashboard that flags deterioration for proactive intervention. UK deployments include Guy's and St Thomas' and Airedale NHS Foundation Trusts, Nuffield Health, LloydsPharmacy Clinical Homecare, Aviva and a Macmillan Cancer Support partnership. In the United States, Evolent integrated Careology into its cancer navigation services from 2024 for Florida Blue and American Oncology Network patients, and Oncology Hematology Care uses it to monitor CAR-T patients. The company reports a 17 fold return on investment from avoided admissions and 96 percent of clinicians saying it informed consultations. Careology raised GBP 1.12 million from angel investors in November 2019; later funding was not sourced.
Investors not recorded; see the round sources.
| Round | Year | Amount | Source |
|---|---|---|---|
| Seed · GBP 1.12 million from UK health and technology angel investors (not named) | 2019 | undisclosed | careology.health |
Amounts only where the cited source states them. Rounds without a public source are not listed.
Shares Electronic patient-reported outcomes and remote monitoring, Electronic patient-reported outcome (ePRO) symptom monitoring.
Shares Electronic patient-reported outcomes and remote monitoring, Electronic patient-reported outcome (ePRO) symptom monitoring.
Shares Electronic patient-reported outcomes and remote monitoring, Electronic patient-reported outcome (ePRO) symptom monitoring.
Shares Electronic patient-reported outcomes and remote monitoring, Electronic patient-reported outcome (ePRO) symptom monitoring.
Shares Electronic patient-reported outcomes and remote monitoring, Electronic patient-reported outcome (ePRO) symptom monitoring.